WeVote
Log In

Bill

Bill

SD 621

An Act ensuring access to specialty medications

194th Legislature (2025-2026) Introduced by Jamie Eldridge

Massachusetts bill requires health insurers to improve patient access to specialty medications, likely by reducing prior authorization barriers and cost-sharing for high-cost drugs used in serious illnesses.

House concurred
0
WeVote Research Nonpartisan
Bill Summary · SD 621

Legislative bill overview

SD 621 requires health insurance plans to ensure patient access to specialty medications, likely by limiting prior authorization requirements, reducing cost-sharing barriers, or establishing clear coverage pathways for high-cost drugs. The bill addresses concerns that insurance companies create administrative hurdles preventing patients from obtaining necessary specialty drugs like biologics and targeted therapies.

Why is this important

Specialty medications treat serious conditions like cancer, autoimmune diseases, and rare disorders but often cost thousands monthly, making insurance coverage decisions critical to patient health outcomes. Restrictive prior authorization and high out-of-pocket costs can delay or prevent patients from accessing these life-saving treatments, creating a significant public health and equity issue.

Potential points of contention

  • Cost implications: Health insurers will likely argue expanded access increases premiums for all policyholders; supporters counter that preventing delays in specialty drug access reduces emergency room visits and complications
  • Scope ambiguity: The bill's specific definition of "specialty medications" and "access" requirements remain unclear without seeing the full text; insurers may resist broad interpretations while patient advocates may push for expansive coverage
  • Prior authorization balance: Determining how much to restrict prior authorization involves weighing patient access against fraud prevention and appropriate utilization; different stakeholders have fundamentally different risk tolerances

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.